ENO1 and familial pancreatic carcinoma: Wang et al. discovered the role of ENO1 in hypoxia-induced gemcitabine chemoresistance, decreased expression of which restored sensitivity to chemotherapy by modulating redox homeostasis in pancreatic cancer cells [48].